Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
World J Diabetes ; 6(3): 527-33, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25897362

ABSTRACT

AIM: To investigate whether perceptions of task difficulty on neuropsychological tests predicted academic achievement after controlling for glucose levels and depression. METHODS: Participants were type 1 diabetic adolescents, with a mean age = 12.5 years (23 females and 16 males), seen at a northwest suburban Chicago hospital. The sample population was free of co-morbid clinical health conditions. Subjects completed a three-part neuropsychological battery including the Digit Symbol Task, Trail Making Test, and Controlled Oral Word Association test. Following each task, individuals rated task difficulty and then completed a depression inventory. Performance on these three tests is reflective of neuropsychological status in relation to glucose control. Blood glucose levels were measured immediately prior to and after completing the neuropsychological battery using a glucose meter. HbA1c levels were obtained from medical records. Academic performance was based on self-reported grades in Math, Science, and English. Data was analyzed using multiple regression models to evaluate the associations between academic performance, perception of task difficulty, and glucose control. RESULTS: Perceptions of difficulty on a neuropsychological battery significantly predicted academic performance after accounting for glucose control and depression. Perceptions of difficulty on the neuropsychological tests were inversely correlated with academic performance (r = -0.48), while acute (blood glucose) and long-term glucose levels increased along with perceptions of task difficulty (r = 0.47). Additionally, higher depression scores were associated with poorer academic performance (r = -0.43). With the first regression analysis, perception of difficulty on the neuropsychological tasks contributed to 8% of the variance in academic performance after controlling for peripheral blood glucose and depression. In the second regression analysis, perception of difficulty accounted for 11% of the variance after accounting for academic performance and depression. The final regression analysis indicated that perception of difficulty increased with peripheral blood glucose, contributing to 22% of the variance. Most importantly, after controlling for perceptions of task difficulty, academic performance no longer predicted glucose levels. Finally, subjects who found the cognitive battery difficult were likely to have poor academic grades. CONCLUSION: Perceptions of difficulty on neurological tests exhibited a significant association with academic achievement, indicating that deficits in this skill may lead to academic disadvantage in diabetic patients.

2.
Proc Natl Acad Sci U S A ; 109(9): 3540-5, 2012 Feb 28.
Article in English | MEDLINE | ID: mdl-22331903

ABSTRACT

N-acetylserotonin (NAS) is synthesized from serotonin by arylalkylamine N-acetyltransferase (AANAT), which is predominantly expressed in the pineal gland and retina. NAS activates TrkB in a circadian manner and exhibits antidepressant effects in a TrkB-dependent manner. It also enhances neurogenesis in hippocampus in sleep-deprived mice. Here we report the identification of NAS derivatives that possess much more robust neurotrophic effects with improved pharmacokinetic profiles. The compound N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide (HIOC) selectively activates TrkB receptor with greater potency than NAS. It potently protects retinas from light-induced retinal degeneration (LIRD), which is tightly coupled with pronounced TrkB activation in retinas. Pharmacokinetic studies demonstrate that this compound is stable in serum and liver microsomes. It can pass the blood-brain barrier and blood-retinal barrier. Hence, HIOC is a good lead compound for further drug development for treating retinal degenerative diseases.


Subject(s)
Indoles/therapeutic use , Neurons/drug effects , Neuroprotective Agents/pharmacology , Piperidines/therapeutic use , Receptor, trkB/agonists , Serotonin Receptor Agonists/pharmacology , Adenylate Kinase/metabolism , Animals , Blood-Brain Barrier , Blood-Retinal Barrier , Brain-Derived Neurotrophic Factor/pharmacology , Cells, Cultured/drug effects , Cerebral Cortex/cytology , Drug Evaluation, Preclinical , Half-Life , Indoles/pharmacokinetics , Indoles/pharmacology , Injections, Intraperitoneal , Mice , Microsomes, Liver/metabolism , Neuroprotective Agents/pharmacokinetics , Phosphorylation/drug effects , Phosphorylation/radiation effects , Piperidines/pharmacokinetics , Piperidines/pharmacology , Protein Processing, Post-Translational/drug effects , Protein Processing, Post-Translational/radiation effects , Rats , Retina/drug effects , Serotonin Receptor Agonists/pharmacokinetics , Signal Transduction/drug effects , Signal Transduction/radiation effects , Tissue Distribution
3.
J Neurosci ; 30(8): 3101-12, 2010 Feb 24.
Article in English | MEDLINE | ID: mdl-20181607

ABSTRACT

Notch signaling is known to play important roles during retinal development. Recently, Notch signaling has been shown to be active in proliferating Müller glia in acutely damaged chick retina (Hayes et al., 2007). However, the roles of Notch in mature, undamaged retina remain unknown. Thus, the purpose of this study was to determine the role of the Notch-signaling pathway in the postnatal retina. Here we show that components of the Notch-signaling pathway are expressed in most Müller glia at low levels in undamaged retina. The expression of Notch-related genes varies during early postnatal development and across regions, with higher expression in peripheral versus central retina. Blockade of Notch activity with a small molecule inhibitor before damage was protective to retinal interneurons (amacrine and bipolar cells) and projection neurons (ganglion cells). In the absence of damage, Notch is upregulated in retinas treated with insulin and FGF2; the combination of these factors is known to stimulate the proliferation and dedifferentiation of Müller glia (Fischer et al., 2002b). Inhibition of Notch signaling during FGF2 treatment reduces levels of the downstream effectors of the MAPK-signaling pathway-p38 MAPK and pCREB in Müller glia. Further, inhibition of Notch activity potently inhibits FGF2-induced proliferation of Müller glia. Together, our data indicate that Notch signaling is downstream of, and is required for, FGF2/MAPK signaling to drive the proliferation of Müller glia. In addition, our data suggest that low levels of Notch signaling in Müller glia diminish the neuroprotective activities of these glial cells.


Subject(s)
Cell Proliferation/drug effects , Cytoprotection/physiology , Neuroglia/metabolism , Receptors, Notch/metabolism , Retina/metabolism , Signal Transduction/physiology , Amacrine Cells/drug effects , Amacrine Cells/metabolism , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cell Survival/physiology , Chickens , Cyclic AMP Response Element-Binding Protein/metabolism , Cytoprotection/drug effects , Enzyme Inhibitors/pharmacology , Fibroblast Growth Factor 2/metabolism , Fibroblast Growth Factor 2/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology , Neuroglia/cytology , Neuroglia/drug effects , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Receptors, Notch/antagonists & inhibitors , Receptors, Notch/genetics , Repressor Proteins/genetics , Repressor Proteins/metabolism , Retina/cytology , Retinal Bipolar Cells/drug effects , Retinal Bipolar Cells/metabolism , Retinal Ganglion Cells/drug effects , Retinal Ganglion Cells/metabolism , Signal Transduction/drug effects , Transcription Factor HES-1 , Triglycerides/pharmacology , gamma-Aminobutyric Acid/analogs & derivatives , gamma-Aminobutyric Acid/pharmacology
4.
J Dev Behav Pediatr ; 30(6): 499-508, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19861900

ABSTRACT

OBJECTIVE: Children with medical conditions often experience a combination of positive and negative social interactions with parents and friends. Adult research examining cross-domain buffering effects has documented that supportive social ties can make up for shortcomings in other social relationships. This study examined whether negative effects of strained relationships with loved ones can be buffered when children feel supported by individuals in different support networks (i.e., cross-domain buffering effects). METHOD: Children with Type I diabetes (n = 56), chronic asthma (n = 54), and cystic fibrosis (n = 17) completed questionnaires during an outpatient hospital visit that assessed perceptions of support and strain from parents and friends, quality of life, self-concept, and emotional/behavioral difficulties. Parental strain was conceptualized as parental overprotection and parental rejection. RESULTS: Hierarchical regression analyses showed that friend support buffered the adverse effects of parental strain on child quality of life, self-concept, and emotional/behavioral difficulties. Interestingly, parental support did not buffer the negative effects of experiencing strained relationships with friends; only main effects on outcome were found. These findings partially support our hypotheses of cross-domain buffering. CONCLUSIONS: In this study, friendships were a protective factor for children who experienced strained relationships with parents. In contrast, although parent support had a direct impact on child outcome, it did not make up for feeling rejected by friends. Because close relationships are often strained during medical stressors, findings underscore the importance of promoting social connectedness in chronically ill children to maximize opportunities for experiencing positive social relationships.


Subject(s)
Chronic Disease , Friends/psychology , Parents/psychology , Social Support , Adolescent , Asthma , Behavior , Child , Cystic Fibrosis , Diabetes Mellitus, Type 1 , Emotions , Female , Humans , Interpersonal Relations , Male , Quality of Life , Regression, Psychology , Self Concept , Surveys and Questionnaires
5.
J Neurochem ; 111(1): 1-14, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19619137

ABSTRACT

The neurotransmitter serotonin is synthesized in the retina by one type of amacrine neuron but accumulates in bipolar neurons in many vertebrates. The mechanisms, functions and purpose underlying serotonin accumulation in bipolar cells remain unknown. Here, we demonstrate that exogenous serotonin transiently accumulates in a distinct type of bipolar neuron. KCl-mediated depolarization causes the depletion of serotonin from amacrine neurons and, subsequently, serotonin is taken-up by bipolar neurons. The accumulation of endogenous and exogenous serotonin by bipolar neurons is blocked by selective reuptake inhibitors. Exogenous serotonin is specifically taken-up by bipolar neurons even when serotonin-synthesizing amacrine neurons are destroyed; excluding the possibility that serotonin diffuses through gap junctions from amacrine into bipolar neurons. Further, inhibition of monoamine oxidase A prevents the degradation of serotonin in bipolar neurons, suggesting that monoamine oxidase A is present in these neurons. However, the vesicular monoamine transporter 2 is present only in amacrine cells suggesting that serotonin is not transported into synaptic vesicles and reused as a transmitter in the bipolar neurons. We conclude that the serotonin-accumulating bipolar neurons perform glial functions in the retina by actively transporting and degrading serotonin that is synthesized in neighboring amacrine cells.


Subject(s)
Amacrine Cells/metabolism , Retina/cytology , Retinal Bipolar Cells/metabolism , Serotonin/metabolism , Amacrine Cells/drug effects , Animals , Animals, Newborn , Chickens , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Homeodomain Proteins/metabolism , Potassium Chloride/pharmacology , Retinal Bipolar Cells/drug effects , Serotonin/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Sertraline/pharmacology , Vesicular Monoamine Transport Proteins/genetics , Vesicular Monoamine Transport Proteins/metabolism , Zimeldine/pharmacology
6.
Brain Res ; 1192: 76-89, 2008 Feb 04.
Article in English | MEDLINE | ID: mdl-17320838

ABSTRACT

A circumferential marginal zone (CMZ) of retinal progenitors has been identified in most vertebrate classes, with the exception of mammals. Little is known about the formation of the CMZ during late stages of embryonic retinal histogenesis. Thus, the purpose of this study was to characterize the formation and patterning of the CMZ in the embryonic chicken retina. We identified progenitors by assaying for the expression of proliferating cell nuclear antigen (PCNA), N-cadherin and the nestin-related filament transitin, and newly generated cells by using BrdU-birthdating. We found that there is a gradual spatial restriction of progenitors into a discreet CMZ during late stages of embryonic development between E16 and hatching, at about E21. In addition, we found that retinal neurons remain immature for prolonged periods of time in far peripheral regions of the retina. Early markers of neuronal differentiation (such as HuC/D, calretinin and visinin) are expressed by neurons that are found directly adjacent to the CMZ. By contrast, genes (protein kinase C, calbindin, red/green opsin) that are expressed with a delay (7-10 days) after terminal mitosis in the central retina are not expressed until as many as 30 days after terminal mitosis in the far peripheral retina. We conclude that the neurons that are generated by late-stage CMZ progenitors differentiate much more slowly than neurons generated during early stages of retinal development. We propose that the microenvironment within the far peripheral retina at late stages of development permits the maintenance of a zone of progenitors and slows the differentiation of neurons.


Subject(s)
Body Patterning/genetics , Cell Differentiation/genetics , Neurons/metabolism , Retina/embryology , Stem Cells/metabolism , Animals , Biomarkers/metabolism , Cell Lineage/genetics , Chick Embryo , Extracellular Fluid/chemistry , Extracellular Fluid/metabolism , Fluorescent Antibody Technique , Gene Expression Regulation, Developmental/genetics , Mitosis/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/cytology , Photoreceptor Cells, Vertebrate/cytology , Photoreceptor Cells, Vertebrate/metabolism , Retina/cytology , Retina/metabolism , Stem Cells/cytology , Time Factors
7.
J Comp Neurol ; 503(4): 538-49, 2007 Aug 01.
Article in English | MEDLINE | ID: mdl-17534934

ABSTRACT

We have recently described large, unipolar neurons (named bullwhip cells) that regulate the proliferation of progenitors in the circumferential marginal zone (CMZ) of the postnatal chicken retina (Fischer et al. [2005] J. Neurosci. 25:10157-10166; [2006] J. Comp. Neurol. 496:479-494). There are only about 240 bullwhip cells in the entire retina, and these cells are easily identified by their unique morphology and immunoreactivity for glucagon, glucagon-like peptide 1 (GLP1), and substance P. The purpose of this study was to elucidate the development of bullwhip cells in the embryonic chicken retina. By using bromodeoxyuridine birth dating, we found that the bullwhip cells are generated very early during retinal development, between E4 and E5. Glucagon peptide was first detected in bullwhip cells at about E10, whereas substance P was not detected in the bullwhip cells until E15. Although glucagon peptide is not present during early stages of retinal development, we detected mRNA for glucagon receptor beginning at E7 and mRNA for GLP1 receptor at E5 through E14. Morphological differentiation of the bullwhip cells begins at about E14 and is completed by E18. The bullwhip cells are greatly overproduced, and nearly 80% of these cells undergo apoptotic cell death during late stages of embryonic development. The bullwhip cells that survive are those that project an axon-like process directly toward the CMZ; the cells that project in an inappropriate direction fail to survive. We conclude that cells fated to become bullwhip neurons are generated long before they begin to differentiate and that their survival depends on the orientation of their primary neurite.


Subject(s)
Gene Expression Regulation, Developmental/physiology , Neurons/physiology , Retina/cytology , Retina/embryology , Animals , Bromodeoxyuridine/metabolism , Caspase 3/metabolism , Chick Embryo , Glucagon-Like Peptide-1 Receptor , Glucagon-Like Peptide-2 Receptor , Neurons/classification , Neurons/metabolism , RNA, Messenger/biosynthesis , Receptors, Glucagon/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Substance P/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...